Erratum: "Viperin restricts Zika virus and tick-borne encephalitis virus replication by targeting NS3 for proteasomal degradation [Journal of Virology, 92, 7, e02054-17, (2018)] 10.1128/JVI.02054-17;Viperin restricts Zika virus and tick-borne encephalitis virus replication by targeting NS3 for proteasomal degradation

Journal of Virology

Volumn 92, Issue 7, 2018, Pages

  Panayiotou, Christakis ^a   Lindqvist, Richard ^a   Kurhade, Chaitanya ^a   Vonderstein, Kirstin ^a,b   Pasto, Jenny ^a   Edlund, Karin ^a   Upadhyay, Arunkumar S ^a   Överby, Anna K ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Flavivirus; Interferons; ISG; NS3; Proteasomal degradation; Viperin

Indexed keywords

NONSTRUCTURAL PROTEIN 3; PROTEASOME; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VIPERIN; NS3 PROTEIN, FLAVIVIRUS; PROTEIN; RNA HELICASE; RSAD2 PROTEIN, HUMAN; SERINE PROTEINASE; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; TICK BORNE ENCEPHALITIS VIRUS; VIRUS REPLICATION; ZIKA VIRUS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY;

ENCEPHALITIS VIRUSES, TICK-BORNE; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNITY, INNATE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; PROTEOLYSIS; RNA HELICASES; SERINE ENDOPEPTIDASES; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION; ZIKA VIRUS;

EID: 85043772814     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00501-18     Document Type: Erratum

References (42)

1. Gould EA, Solomon T. 2008. Pathogenic flaviviruses. Lancet 371: 500-509. https://doi.org/10.1016/S0140-6736(08)60238-X
2. Lazear HM, Diamond MS. 2016. Zika virus: new clinical syndromes and its emergence in the Western Hemisphere. J Virol 90:4864-4875. https:// doi.org/10.1128/JVI.00252-16
3. Fernandez-Garcia MD, Mazzon M, Jacobs M, Amara A. 2009. Pathogenesis of flavivirus infections: using and abusing the host cell. Cell Host Microbe 5:318-328. https://doi.org/10.1016/j.chom.2009.04.001
4. Schneider WM, Chevillotte MD, Rice CM. 2014. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32:513-545. https://doi.org/10.1146/annurev-immunol-032713-120231
5. Schoggins JW. 2014. Interferon-stimulated genes: roles in viral pathogenesis. Curr Opin Virol 6:40-46. https://doi.org/10.1016/j.coviro.2014.03.006
6. Upadhyay AS, Stehling O, Panayiotou C, Rosser R, Lill R, Overby AK. 18 August 2017. Cellular requirements for iron-sulfur cluster insertion into the antiviral radical SAM protein viperin. J Biol Chem. https://doi.org/10.1074/jbc.M117.780122
7. Upadhyay AS, Vonderstein K, Pichlmair A, Stehling O, Bennett KL, Dobler G, Guo JT, Superti-Furga G, Lill R, Overby AK, Weber F. 2014. Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity. Cell Microbiol 16:834-848. https://doi.org/10.1111/cmi.12241
8. Tan KS, Olfat F, Phoon MC, Hsu JP, Howe JL, Seet JE, Chin KC, Chow VT. 2012. In vivo and in vitro studies on the antiviral activities of viperin against influenza H1N1 virus infection. J Gen Virol 93:1269-1277. https:// doi.org/10.1099/vir.0.040824-0
9. Wang X, Hinson ER, Cresswell P. 2007. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2:96-105. https://doi.org/10.1016/j.chom.2007.06.009
10. Nasr N, Maddocks S, Turville SG, Harman AN, Woolger N, Helbig KJ, Wilkinson J, Bye CR, Wright TK, Rambukwelle D, Donaghy H, Beard MR, Cunningham AL. 2012. HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 120:778-788. https://doi.org/10.1182/blood-2012-01-407395
11. Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH, Lulla A, Yeo NK, Koh EG, Chow A, Leo YS, Merits A, Chin KC, Ng LF. 2012. Viperin restricts chikungunya virus replication and pathology. J Clin Invest 122: 4447-4460. https://doi.org/10.1172/JCI63120
12. Zhang Y, Burke CW, Ryman KD, Klimstra WB. 2007. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81:11246-11255. https://doi.org/10.1128/JVI.01282-07
13. McGillivary G, Jordan ZB, Peeples ME, Bakaletz LO. 2013. Replication of respiratory syncytial virus is inhibited by the host defense molecule viperin. J Innate Immun 5:60-71. https://doi.org/10.1159/000342473
14. Peña Cárcamo JR, Morell ML, Vázquez CA, Vatansever S, Upadhyay AS, överby AK, Cordo SM, García CC. 2017. The interplay between viperin antiviral activity, lipid droplets and Junin mammarenavirus multiplication. Virology 514:216-229. https://doi.org/10.1016/j.virol.2017.10.012
15. Helbig KJ, Carr JM, Calvert JK, Wati S, Clarke JN, Eyre NS, Narayana SK, Fiches GN, McCartney EM, Beard MR. 2013. Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Negl Trop Dis 7:e2178. https:// doi.org/10.1371/journal.pntd.0002178
16. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, Zhang X, Birk A, Chang J, Shi PY, Block TM, Guo JT. 2010. Identification of five interferoninduced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 84:8332-8341. https://doi.org/10.1128/JVI.02199-09
17. Szretter KJ, Brien JD, Thackray LB, Virgin HW, Cresswell P, Diamond MS. 2011. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J Virol 85:11557-11566. https://doi.org/10.1128/JVI.05519-11
18. Wang S, Wu X, Pan T, Song W, Wang Y, Zhang F, Yuan Z. 2012. Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33. J Gen Virol 93:83-92. https://doi.org/10.1099/ vir.0.033860-0
19. Van der Hoek KH, Eyre NS, Shue B, Khantisitthiporn O, Glab-Ampi K, Carr JM, Gartner MJ, Jolly LA, Thomas PQ, Adikusuma F, Jankovic-Karasoulos T, Roberts CT, Helbig KJ, Beard MR. 2017. Viperin is an important host restriction factor in control of Zika virus infection. Sci Rep 7:4475. https://doi.org/10.1038/s41598-017-04138-1
20. Bartholomeusz AI, Wright PJ. 1993. Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5. Arch Virol 128:111-121. https://doi.org/10.1007/BF01309792
21. Falgout B, Pethel M, Zhang YM, Lai CJ. 1991. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 65:2467-2475
22. Gebhard LG, Iglesias NG, Byk LA, Filomatori CV, De Maio FA, Gamarnik AV. 2016. A proline-rich N-terminal region of the dengue virus NS3 is crucial for infectious particle production. J Virol 90:5451-5461. https:// doi.org/10.1128/JVI.00206-16
23. Patkar CG, Kuhn RJ. 2008. Yellow fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol 82:3342-3352. https://doi.org/10.1128/JVI.02447-07
24. Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, Lin YL. 2012. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog 8:e1002780. https://doi.org/10.1371/journal.ppat.1002780
25. Lin JH, Walter P, Yen TS. 2008. Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol 3:399-425. https://doi.org/10.1146/ annurev.pathmechdis.3.121806.151434
26. Oslowski CM, Urano F. 2011. Measuring ER stress and the unfolded protein response using mammalian tissue culture system. Methods Enzymol 490: 71-92. https://doi.org/10.1016/B978-0-12-385114-7.00004-0
27. Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, Block TM, Guo JT. 2008. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82:1665-1678. https://doi.org/ 10.1128/JVI.02113-07
28. Chan YL, Chang TH, Liao CL, Lin YL. 2008. The cellular antiviral protein viperin is attenuated by proteasome-mediated protein degradation in Japanese encephalitis virus-infected cells. J Virol 82:10455-10464. https://doi.org/10.1128/JVI.00438-08
29. Liu WJ, Sedlak PL, Kondratieva N, Khromykh AA. 2002. Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly. J Virol 76: 10766-10775. https://doi.org/10.1128/JVI.76.21.10766-10775.2002
30. Jumat MR, Huong TN, Ravi LI, Stanford R, Tan BH, Sugrue RJ. 2015. Viperin protein expression inhibits the late stage of respiratory syncytial virus morphogenesis. Antiviral Res 114:11-20. https://doi.org/10.1016/j.antiviral.2014.11.007
31. Eldin P, Papon L, Oteiza A, Brocchi E, Lawson TG, Mechti N. 2009. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J Gen Virol 90:536-545. https://doi.org/10.1099/vir.0.006288-0
32. Xue B, Yang D, Wang J, Xu Y, Wang X, Qin Y, Tian R, Chen S, Xie Q, Liu N, Zhu H. 2016. ISG12a restricts hepatitis C virus infection through the ubiquitination-dependent degradation pathway. J Virol 90:6832-6845. https://doi.org/10.1128/JVI.00352-16
33. Taylor RT, Lubick KJ, Robertson SJ, Broughton JP, Bloom ME, Bresnahan WA, Best SM. 2011. TRIM79alpha, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10:185-196. https://doi.org/10.1016/ j.chom.2011.08.004
34. Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, Kuhn RJ, Randall G. 2010. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A 107:17345-17350. https://doi.org/10.1073/pnas.1010811107
35. Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, Maringer K, Bernal-Rubio D, Shabman RS, Simon V, Rodriguez-Madoz JR, Mulder LC, Barber GN, Fernandez-Sesma A. 2012. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 8:e1002934. https://doi.org/10.1371/journal.ppat.1002934
36. Lindqvist R, Mundt F, Gilthorpe JD, Wolfel S, Gekara NO, Kroger A, Overby AK. 2016. Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects. J Neuroinflammation 13:277. https://doi.org/10.1186/s12974-016-0748-7
37. Vonderstein K, Nilsson E, Hubel P, Nygard Skalman L, Upadhyay A, Pasto J, Pichlmair A, Lundmark R, Overby AK. 2017. Viperin targets flavivirus virulence by inducing assembly of noninfectious capsid particles. J Virol. https://doi.org/10.1128/JVI.01751-17
38. Asghar N, Lee YP, Nilsson E, Lindqvist R, Melik W, Kroger A, Overby AK, Johansson M. 2016. The role of the poly(A) tract in the replication and virulence of tick-borne encephalitis virus. Sci Rep 6:39265. https://doi.org/10.1038/srep39265
39. Donald CL, Brennan B, Cumberworth SL, Rezelj VV, Clark JJ, Cordeiro MT, Freitas de Oliveira Franca R, Pena LJ, Wilkie GS, Da Silva Filipe A, Davis C, Hughes J, Varjak M, Selinger M, Zuvanov L, Owsianka AM, Patel AH, McLauchlan J, Lindenbach BD, Fall G, Sall AA, Biek R, Rehwinkel J, Schnettler E, Kohl A. 2016. Full genome sequence and sfRNA interferon antagonist activity of Zika virus from Recife, Brazil. PLoS Negl Trop Dis 10:e0005048. https://doi.org/10.1371/journal.pntd.0005048
40. Niedrig M, Klockmann U, Lang W, Roeder J, Burk S, Modrow S, Pauli G. 1994. Monoclonal antibodies directed against tick-borne encephalitis virus with neutralizing activity in vivo. Acta Virol 38:141-149
41. Mutso M, Saul S, Rausalu K, Susova O, Zusinaite E, Mahalingam S, Merits A. 2017. Reverse genetic system, genetically stable reporter viruses and packaged subgenomic replicon based on a Brazilian Zika virus isolate. J Gen Virol 98:2712-2724. https://doi.org/10.1099/jgv.0.000938
42. Overby AK, Popov VL, Niedrig M, Weber F. 2010. Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol 84:8470-8483. https://doi.org/ 10.1128/JVI.00176-10